Spesolimab Speeds Lesion Clearance in Rare Type Of Psoriasis Spesolimab Speeds Lesion Clearance in Rare Type Of Psoriasis

The anti-interleukin 36 receptor monoclonal antibody is under priority review at the Food and Drug Administration for treating GPP flares.Medscape Medical News
Source: Medscape Rheumatology Headlines - Category: Rheumatology Tags: Dermatology News Source Type: news